Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd (688505) — Cash Flow-to-Debt Ratio
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd (688505) has a Cash Flow-to-Debt Ratio of 0.21x as of September 2025, meaning its operating cash flow of CN¥43.77 Million could theoretically repay 0% of its total liabilities (CN¥207.05 Million) in one year. See 688505 FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd Cash Flow-to-Debt Ratio (2006–2025)
Historical debt coverage capacity for Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd across 20 annual periods. Also explore how fast is Shanghai Fudan-Zhangjiang Bio-Pharmaceut growing its equity to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd (2006–2025)
Year-by-year debt coverage analysis for Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd. For market capitalisation and broader financial context, see 688505 market cap overview.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.52x | CN¥141.40 Million | CN¥273.93 Million | ▲ +1082.8% |
| 2024 | -0.05x | CN¥-14.77 Million | CN¥281.23 Million | ▼ -138.3% |
| 2023 | 0.14x | CN¥71.02 Million | CN¥518.12 Million | ▼ -40.0% |
| 2022 | 0.23x | CN¥165.27 Million | CN¥722.99 Million | ▼ -49.7% |
| 2021 | 0.45x | CN¥268.90 Million | CN¥591.58 Million | ▲ +98.0% |
| 2020 | 0.23x | CN¥113.00 Million | CN¥492.21 Million | ▼ -46.1% |
| 2019 | 0.43x | CN¥269.23 Million | CN¥631.68 Million | ▲ +14.2% |
| 2018 | 0.37x | CN¥173.94 Million | CN¥466.08 Million | ▲ +120.8% |
| 2017 | 0.17x | CN¥42.71 Million | CN¥252.65 Million | ▼ -70.2% |
| 2016 | 0.57x | CN¥140.57 Million | CN¥247.70 Million | ▲ +49.9% |
| 2015 | 0.38x | CN¥96.30 Million | CN¥254.43 Million | ▼ -36.6% |
| 2014 | 0.60x | CN¥88.36 Million | CN¥148.06 Million | ▲ +22.3% |
| 2013 | 0.49x | CN¥89.44 Million | CN¥183.29 Million | ▲ +22.8% |
| 2012 | 0.40x | CN¥110.19 Million | CN¥277.18 Million | ▲ +26.5% |
| 2011 | 0.31x | CN¥49.59 Million | CN¥157.81 Million | ▲ +698.8% |
| 2010 | -0.05x | CN¥-7.11 Million | CN¥135.45 Million | ▼ -188.6% |
| 2009 | 0.06x | CN¥7.72 Million | CN¥130.46 Million | ▲ +130.8% |
| 2008 | -0.19x | CN¥-15.89 Million | CN¥82.57 Million | ▲ +33.6% |
| 2007 | -0.29x | CN¥-17.18 Million | CN¥59.34 Million | ▲ +41.4% |
| 2006 | -0.49x | CN¥-21.40 Million | CN¥43.32 Million | — |